| Literature DB >> 2766866 |
A Kumar1, R Wofford-McQueen, R C Gordon.
Abstract
For 16 isolates of Pseudomonas cepacia from patients with cystic fibrosis, synergism was determined by the killing curve method, utilizing various combinations of antibiotics [ticarcillin (Ti), rifampin (Ri), tobramycin (To), imipenem (Im), ofloxacin (Of), polymyxin B (PB), and trimethoprim/sulfamethoxazole (S x T)]. All 16 isolates were resistant to Ti, To, Ri, and PB; 11 were sensitive to S x T, 13 were sensitive to Im, and 2 were sensitive to Of. The combination of Im/Ri was synergistic for 8 isolates. Several combinations (Ti/Ri/Im), (Ti/Im/To), (Ri/Im/To) also demonstrated synergism for these 8 isolates. The Im/Ri combination did not demonstrate synergism against the other 8 isolates. The Ti/Im/To combination was synergistic for 6 of these. The Ri/Im/To combination was synergistic for 5 and the Ti/Im/Ri combination was synergistic for 3. Synergism could also be demonstrated with several 4-drug combinations. This study suggests that multi-drug combinations may have a role in the treatment of P. cepacia infections if proven in clinical studies.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2766866 DOI: 10.1159/000238678
Source DB: PubMed Journal: Chemotherapy ISSN: 0009-3157 Impact factor: 2.544